1. Home
  2. XOMA vs QUAD Comparison

XOMA vs QUAD Comparison

Compare XOMA & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • QUAD
  • Stock Information
  • Founded
  • XOMA 1981
  • QUAD 1971
  • Country
  • XOMA United States
  • QUAD United States
  • Employees
  • XOMA N/A
  • QUAD N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • QUAD Publishing
  • Sector
  • XOMA Health Care
  • QUAD Consumer Discretionary
  • Exchange
  • XOMA Nasdaq
  • QUAD Nasdaq
  • Market Cap
  • XOMA 294.2M
  • QUAD 261.9M
  • IPO Year
  • XOMA N/A
  • QUAD 2010
  • Fundamental
  • Price
  • XOMA $24.79
  • QUAD $6.03
  • Analyst Decision
  • XOMA Strong Buy
  • QUAD Strong Buy
  • Analyst Count
  • XOMA 2
  • QUAD 2
  • Target Price
  • XOMA $69.50
  • QUAD $9.45
  • AVG Volume (30 Days)
  • XOMA 17.9K
  • QUAD 366.6K
  • Earning Date
  • XOMA 05-20-2025
  • QUAD 04-29-2025
  • Dividend Yield
  • XOMA N/A
  • QUAD 5.08%
  • EPS Growth
  • XOMA N/A
  • QUAD N/A
  • EPS
  • XOMA N/A
  • QUAD N/A
  • Revenue
  • XOMA $28,487,000.00
  • QUAD $2,646,800,000.00
  • Revenue This Year
  • XOMA $17.89
  • QUAD N/A
  • Revenue Next Year
  • XOMA $34.58
  • QUAD N/A
  • P/E Ratio
  • XOMA N/A
  • QUAD N/A
  • Revenue Growth
  • XOMA 498.72
  • QUAD N/A
  • 52 Week Low
  • XOMA $18.35
  • QUAD $4.06
  • 52 Week High
  • XOMA $35.00
  • QUAD $9.13
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 62.87
  • QUAD 65.47
  • Support Level
  • XOMA $22.91
  • QUAD $4.50
  • Resistance Level
  • XOMA $25.17
  • QUAD $5.51
  • Average True Range (ATR)
  • XOMA 1.13
  • QUAD 0.32
  • MACD
  • XOMA 0.08
  • QUAD 0.13
  • Stochastic Oscillator
  • XOMA 78.43
  • QUAD 94.43

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

Share on Social Networks: